Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Immunovia AB ( (SE:IMMNOV) ) just unveiled an announcement.
Immunovia AB has announced an Extraordinary General Meeting (EGM) to discuss significant amendments to its Articles of Association to facilitate a proposed rights issue of shares. This move aims to adjust the company’s share capital and number of shares, with the board proposing multiple alternatives for the amendment, reflecting the company’s strategic focus on optimizing its financial structure.
More about Immunovia AB
Average Trading Volume: 7,956,228
Technical Sentiment Signal: Buy
Current Market Cap: SEK293.8M
For an in-depth examination of IMMNOV stock, go to TipRanks’ Overview page.